H. B. Fuller (FUL) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended November 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on January 1 ...

Company Performance - H.B. Fuller Company's shares have declined by 16.4% in the past month, underperforming its industry's decline of 8% and the S&P 500's decline of approximately 1.9% [1][2] Financial Guidance - The company has issued preliminary financial results for fiscal 2024, projecting net revenues of approximately $3.57 billion, adjusted earnings per share of around $3.84, and adjusted EBITDA of roughly $594 million, which is a decrease from the previous guidance of $610-$620 million [3] - H.B. Fuller plans to generate around $300 million in cash flow from operations for the year [3] Earnings Performance - The fourth-quarter net revenues and earnings were negatively impacted by weaker-than-expected market conditions and delayed orders, particularly in consumer product and packaging-related industries, as well as durable goods distribution [4] - The company's earnings missed the Zacks Consensus Estimate by 8.9% in the last reported quarter, with earnings estimates for fiscal 2024 and 2025 declining over the past 60 days [5]

H.B. Fuller Company (FUL) has issued unaudited preliminary financial results for fiscal 2024. These preliminary results are estimates and subject to the conclusion of the company's fiscal-year financial audit.FUL now expects fiscal 2024 net revenues to be roughly $3.57 billion, adjusted earnings per share to be about $3.84 and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to be roughly $594 million compared with the previous guidance of adjusted EBITDA between $610 millio ...

Financial Performance - Net revenue for the third quarter of 2024 increased by 1.9% to $917.9 million compared to $900.6 million in the third quarter of 2023[96]. - Net income attributable to H.B. Fuller in the third quarter of 2024 was $55.4 million, up from $37.6 million in the same quarter of 2023, with diluted earnings per share increasing to $0.98 from $0.67[97]. - For the first nine months of 2024, net revenue increased by 1.4% to $2,645.5 million compared to $2,608.1 million in the first nine months of 2023[97]. - Net income for the first nine months of 2024 was $137.6 million, up 37.7% from $99.9 million in the same period of 2023[119]. - Total net revenue for Q3 2024 was $917.9 million, a decrease of 3.1% compared to $900.6 million in Q3 2023[124]. Cost and Expenses - SG&A expenses for the first nine months of 2024 increased by 6.5% to $525.2 million compared to $493.3 million in the same period of 2023[108]. - The company incurred costs of approximately $43.0 million related to restructuring plans as of August 31, 2024, with total expected costs between $39.1 million and $50.1 million[99]. - Interest expense for the third quarter of 2024 was $35.3 million, slightly up from $35.1 million in the same quarter of 2023[111]. Profitability Metrics - Gross profit margin for the third quarter of 2024 increased by 70 basis points to 30.0%, driven by lower raw material costs[106]. - Organic revenue growth in the third quarter of 2024 was 0.4%, with a 10.2% increase in Construction Adhesives[101]. - Segment operating income for Hygiene, Health and Consumable Adhesives was $49.8 million in Q3 2024, down 5.5% from $52.7 million in Q3 2023[123]. - Segment operating margin for Hygiene, Health and Consumable Adhesives was 12.8% in Q3 2024, compared to 13.1% in Q3 2023[124]. - Segment operating income for Engineering Adhesives remained flat at $52.9 million, while segment operating margin decreased by 40 basis points to 14.1%[129]. - Segment operating income for Construction Adhesives increased by 111.9% to $12.5 million, with segment operating margin rising to 8.2%[132]. Cash Flow and Liquidity - Total cash and cash equivalents as of August 31, 2024, were $131.4 million, down from $179.5 million as of December 2, 2023[137]. - The company expects cash flows from operating activities to be adequate for short-term and long-term liquidity needs[138]. - Net cash provided by operating activities was $216.8 million for the nine months ended August 31, 2024, slightly up from $216.7 million in 2023[146]. - Free cash flow for the first nine months of 2024 was $104.0 million, down from $107.2 million in the same period of 2023[145]. Debt and Capital Structure - Total long and short-term debt increased to $2,021.1 million as of August 31, 2024, compared to $1,838.4 million as of December 2, 2023[137]. - The total debt to total capital ratio was 52.3% as of August 31, 2024, compared to 51.1% as of December 2, 2023[137]. - Total debt to total capital ratio rose to 53.0% in 2024 from 52.2% in 2023[143]. - The company was in compliance with all covenants of its contractual obligations as of August 31, 2024, with a secured total indebtedness to TTM EBITDA ratio of 2.2[139]. Other Income and Investments - Other income, net for the third quarter of 2024 was $2.1 million, a 31.3% increase from $1.6 million in the third quarter of 2023[109]. - Income from equity method investments increased by 30.0% to $1.3 million in Q3 2024, compared to $1.0 million in Q3 2023[117]. Currency Effects - The company experienced a negative currency effect primarily due to a weaker Egyptian pound, Turkish lira, and Brazilian real compared to the U.S. dollar[126]. Inventory and Trade Receivables - Trade receivables, net contributed $26.4 million to cash flow in 2024, down from $79.5 million in 2023[147]. - Inventory usage increased to $62.2 million in 2024 compared to a cash source of $38.2 million in 2023[148]. - Trade payables provided $49.7 million in cash flow in 2024, contrasting with a cash usage of $74.4 million in 2023[148]. Restructuring Plans - The company expects to complete its restructuring plans by fiscal year 2026, with the majority of costs recognized in fiscal 2023 and 2024[99]. - Segment operating loss in Corporate Unallocated decreased by 46.0% in Q3 2024 compared to Q3 2023, attributed to a gain on insurance claims[137].

For the quarter ended August 2024, H. B. Fuller (FUL) reported revenue of $917.93 million, up 1.9% over the same period last year. EPS came in at $1.13, compared to $1.06 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $958.61 million, representing a surprise of -4.24%. The company delivered an EPS surprise of -8.87%, with the consensus EPS estimate being $1.24. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Str ...

分组1 - H. B. Fuller reported quarterly earnings of $1.13 per share, missing the Zacks Consensus Estimate of $1.24 per share, representing an earnings surprise of -8.87% [1] - The company posted revenues of $917.93 million for the quarter ended August 2024, missing the Zacks Consensus Estimate by 4.24%, compared to year-ago revenues of $900.63 million [2] - H. B. Fuller shares have increased by approximately 0.8% since the beginning of the year, underperforming the S&P 500's gain of 20.2% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $1.37 on revenues of $962.5 million, and for the current fiscal year, it is $4.40 on revenues of $3.65 billion [7] - The Zacks Industry Rank for Chemical - Specialty is currently in the bottom 21% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Analysts on Wall Street project that H. B. Fuller (FUL) will announce quarterly earnings of $1.24 per share in its forthcoming report, representing an increase of 17% year over year. Revenues are projected to reach $958.61 million, increasing 6.4% from the same quarter last year. The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this per ...

Investors interested in stocks from the Chemical - Specialty sector have probably already heard of H. B. Fuller (FUL) and Novozymes A/S (NVZMY) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank favors stocks with strong earnings ...

Investors with an interest in Chemical - Specialty stocks have likely encountered both H. B. Fuller (FUL) and CSW Industrials (CSWI) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies wi ...

Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Hawkins (HWKN) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with posi ...